Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_assertion description "[mGluR1 inhibitors (Riluzole or BAY36-7620) inhibited the proliferation of triple negative breast cancer cells in a time- and dose-dependent manner and this inhibition correlated with increased apoptosis as demonstrated by increase in PARP cleavage products and Annexin V staining.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_assertion evidence source_evidence_literature NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_assertion SIO_000772 21681448 NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_assertion wasDerivedFrom befree-20150227 NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_assertion wasGeneratedBy ECO_0000203 NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP239932.RAR21T8_l7VbfdbjKIaF-bMII8xs2wzmQr-5fKVxNsEpc130_provenance.